Gemcitabine and Capecitabine in Patients With Advanced Pancreatic Cancer
Status:
Completed
Trial end date:
2009-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to test the effectiveness and safety of the drug combination of
gemcitabine and capecitabine (Xeloda) in patients with advanced pancreatic cancer.